{"id":"W2967449819","doi":"10.1016/s0140-6736(19)31773-8","title":"Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial","year":2019,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":376,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University","funders":"Janssen Scientific Affairs","keywords":"Secukinumab; Medicine; Clinical endpoint; Psoriasis Area and Severity Index; Internal medicine; Clinical trial; Psoriasis; Population; Randomized controlled trial; Psoriatic arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000471146,0.0002869302,0.001265988,0.00004294575,0.0002195822,0.00002433484,0.000423056,0.0001791574,0.0004149956],"category_scores_gemma":[0.0002259249,0.0001369916,0.0004656639,0.00009748686,0.00006546464,0.00003684929,0.00002555007,0.00007597786,0.0002879253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006406239,"about_ca_system_score_gemma":0.00008029446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001631566,"about_ca_topic_score_gemma":0.00007161769,"domain_scores_codex":[0.9982818,0.0003956282,0.0005111177,0.0003612028,0.00006189946,0.0003883514],"domain_scores_gemma":[0.9936801,0.004971818,0.0002834088,0.0009690486,0.00007218593,0.00002342849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9621215,0.0007270002,0.00000442397,0.000003401008,0.003547121,0.00000109195,0.002403576,0.00009192483,0.00399247,0.0001072942,0.007034201,0.019966],"study_design_scores_gemma":[0.9259526,0.004029991,0.00002744127,0.00001279878,0.001268428,0.000001284422,0.0002225585,0.00009250556,0.01578597,0.0001495284,0.05229895,0.0001579434],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9807888,0.001601843,0.00003656494,0.001129057,0.004773675,0.007431362,0.00281683,0.00004782916,0.001374006],"genre_scores_gemma":[0.9923406,0.0005645166,0.00008300025,0.0001117409,0.001655953,0.001533547,0.0005717196,0.00002540806,0.00311352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04526475,"threshold_uncertainty_score":0.5586354,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04423776972757437,"score_gpt":0.2942113505826859,"score_spread":0.2499735808551115,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}